Guidance document for industry - reporting adverse reactions to marketed health products : Canada Vigilance Adverse Reaction Monitoring Program and database, a program of MedEffect Canada.: H164-33/2011E-PDF
"This guidance document provides Market Authorization Holders (MAHs) with assistance on how to comply with the Food and Drugs Act, the Food and Drug Regulations, and the Natural Health Products Regulations with respect to reporting adverse reactions (ARs) to marketed health products. ARs for marketed health products within the scope of this guidance document are to be reported to the Canada Vigilance Adverse Reaction Monitoring Program of the Marketed Health Products Directorate (MHPD) of Health Canada"--Scope, p. 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.694177&sl=0
| Department/Agency |
|
|---|---|
| Title | Guidance document for industry - reporting adverse reactions to marketed health products : Canada Vigilance Adverse Reaction Monitoring Program and database, a program of MedEffect Canada. |
| Variant title |
|
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Later edition | Reporting adverse reactions to marketed health products |
| Earlier edition | Guidance document for industry - reporting adverse reactions to marketed health products |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | iv, 37 p. |
| ISBN | 978-1-100-17663-5 |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: